FDA Urges Infant-Formula Makers to Tighten Supplier Oversight After Product Recalls
The U.S. FDA on July 13 urged the infant-formula industry and supply-chain partners to exercise substantive oversight of their suppliers following multiple product recalls and recent botulism cases – the…

